Veropharm 9M 2008 Net Profit up 61%
Published: 12 November, 2008, 07:44
Russian pharmaceutical producer, Veropharm, has posted a 9M 2008 Net profit of $26.4 million under IFRS.
The bottom line result is up 60.8% on the same figure for 2007, with EBITDA coming in at $39.4 million, also up 60.8%, on the back of Sales of $128 million, up 39%. The company pointed to a strong performance within the Russian federation, accounting to 96% of its Sales. Prescription drugs increased to account for 64% of sales over the first nine months of the year, with traditional drugs declining to 8%, and Over The Counter medicines and Bandages remaining unchanged at 9% and 19% respectively.
For 3Q 2008, the company posted a Net Profit of $7 million, with EBITDA up 44% year on year to $10.8 million, on the back of Revenue of $41.5 million, up 27% on the 2007 result.
Novatek posts 11% profit increase for 3Q 2008
11.11.2008, 19:57
Central Bank of Russia lifts refinancing rateRussia's Central Bank has increased its refinance rate by 1 percentage point to 12 percent. The aim is to lower capital outflow and restrict inflation. |
12.11.2008, 14:04
Market Watch November 12: A short, sharp, shock - downWith the Micex exchange closed until Thursday, Russian investors were left with following the dollar denominated RTS exchange. As global equities continued to slide, and with crude and commodity prices gaining no traction, it wasn’t that surprising that |
